Dorsey Wright & Associates’s Dova Pharmaceuticals, Inc. Common Stock DOVA Stock Holding History

Dorsey Wright & Associates’s Portfolio DOVA Stock Details DOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-680	Closed	-$19K	–	379
2019 Q3	$19K	Buy	+680	New	+$11K	﹤0.01%	141

Dorsey Wright & Associates's DOVA Position: Q4 2019 in Review

Dorsey Wright & Associates sold out of Dova Pharmaceuticals, Inc. Common Stock (DOVA) in Q4 2019, closing a stake of 680 shares — an estimated $19K sold.

Dorsey Wright & Associates first reported a position in DOVA in Q3 2019 and held it in 1 quarter. The position peaked at $19K in Q3 2019. 0 funds tracked by Wall St. Rank hold DOVA as of Q4 2019.

Dorsey Wright & Associates reported no remaining Dova Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
Dorsey Wright & Associates sold 680 Dova Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $19K.
Dorsey Wright & Associates first reported a position in Dova Pharmaceuticals, Inc. Common Stock in Q3 2019 and held it in 1 quarter.
Dorsey Wright & Associates's Dova Pharmaceuticals, Inc. Common Stock position peaked at $19K in Q3 2019.
0 funds tracked by Wall St. Rank held Dova Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Dorsey Wright & Associates's 13F filing for Q4 2019, filed 31 Jan 2020.